Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Progressive cardiac phenotypes and reduced reversibility from long-term CUGexp RNA expression in a DM1 mouse model
Rong-Chi Hu, Mohammadreza Tabary, Xander H.T. Wehrens, Thomas A. Cooper
Rong-Chi Hu, Mohammadreza Tabary, Xander H.T. Wehrens, Thomas A. Cooper
View: Text | PDF
Research Article Cardiology Genetics

Progressive cardiac phenotypes and reduced reversibility from long-term CUGexp RNA expression in a DM1 mouse model

  • Text
  • PDF
Abstract

Myotonic dystrophy type 1 (DM1) is caused by an expanded CTG repeat in the DMPK gene, resulting in mutant transcripts that form expanded CUG (CUGexp) RNA foci and sequester muscleblind-like (MBNL) RNA-binding proteins. DM1 is multisystemic, with progressive worsening of disease manifestations in affected tissues. Disease progression is attributed to somatic expansion of the CTG repeats with age, resulting in production of CUGexp RNA with enhanced intrinsic toxicity due to increased MBNL sequestration. To determine the degree to which cardiac disease progression can occur independently of repeat expansion, we used a transgenic DM1 mouse model with inducible heart-specific expression of a stable, interrupted 960-CUG-repeat RNA. Sustained CUGexp RNA expression caused progressive cardiac enlargement, contractile dysfunction, conduction delay, myocardial fibrosis, and reduced survival, while MBNL-dependent splicing defects remained static, consistent with the stable repeat length. We also determined the degree of reversibility after different periods of CUGexp RNA expression by shutting off the repeat-containing transgene. Suppression of CUGexp RNA expression rescued cardiac abnormalities, but reversibility declined with longer exposure to the toxic RNA. These findings demonstrate that prolonged expression of stable CUGexp RNA drives progressive cardiac pathology, revealing a mechanism of disease progression in DM1 in addition to somatic expansion.

Authors

Rong-Chi Hu, Mohammadreza Tabary, Xander H.T. Wehrens, Thomas A. Cooper

×

Figure 6

Reversibility of structural parameters are reduced following long-term compared with short-term CUGexp RNA expression.

Options: View larger image (or click on image) Download as PowerPoint
Reversibility of structural parameters are reduced following long-term c...
M-mode echocardiography was performed on CUG960 +dox (teal bars) and CUG960 ±dox (purple bars) mice with short-, medium-, and long-term expression of CUGexp RNA. Dark teal and dark purple bars show results from parallel cohorts on dox for short-, medium- or long-term that either remained on dox for 2 additional months (light teal) or were taken off dox for 2 months (light purple). Dark and light teal bars are from the same animals as are dark and light purple bars. (A) Left ventricle anterior wall thickness in diastole (LVAW; d), (B) LV internal diameter in diastole (LVID; s), and (C) ejection fraction (EF) were evaluated. M+dox indicates average values in MHCrtTA +dox controls (not expressing CUGexp RNA) at the age indicated. (D–F) Reversibility of each parameter was calculated by subtracting values of that parameter from CUG960 ±dox with averaged MHCrtTA +dox control value of the corresponding parameter and time point. n ≥ 4 per group, time point, and sex. Data represent the mean ± SEM and were analyzed using 2-way ANOVA followed by Tukey’s multiple-comparison test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts